ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 137 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is 1.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,643 | -87.1% | 50,400 | -50.0% | 0.00% | – |
| Q2 2023 | $51,408 | -19.0% | 100,800 | 0.0% | 0.00% | – |
| Q1 2023 | $63,504 | +317420.0% | 100,800 | +231.6% | 0.00% | – |
| Q4 2022 | $20 | -100.0% | 30,400 | 0.0% | 0.00% | – |
| Q3 2022 | $52,000 | +2.0% | 30,400 | -26.7% | 0.00% | – |
| Q2 2022 | $51,000 | +88.9% | 41,490 | 0.0% | 0.00% | – |
| Q1 2022 | $27,000 | -40.0% | 41,490 | 0.0% | 0.00% | – |
| Q4 2021 | $45,000 | -40.0% | 41,490 | +0.5% | 0.00% | – |
| Q3 2021 | $75,000 | -30.6% | 41,290 | +1.0% | 0.00% | – |
| Q2 2021 | $108,000 | -26.5% | 40,865 | 0.0% | 0.00% | – |
| Q1 2021 | $147,000 | +38.7% | 40,865 | -2.5% | 0.00% | – |
| Q4 2020 | $106,000 | +86.0% | 41,905 | +85.0% | 0.00% | – |
| Q3 2020 | $57,000 | +1040.0% | 22,655 | +1228.7% | 0.00% | – |
| Q2 2018 | $5,000 | -93.6% | 1,705 | -91.4% | 0.00% | – |
| Q1 2018 | $78,000 | 0.0% | 19,840 | +5.3% | 0.00% | – |
| Q4 2017 | $78,000 | – | 18,840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
| MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
| MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
| Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
| Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
| A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
| EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
| Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
| EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |